B

Biomatter

Biomatter is a startup focused on creating AI-designed custom enzymes that are not found in nature. Their innovative approach leverages artificial intelligence to design enzymes for various applications, potentially transforming industries that rely on biocatalysis. The recent funding will help them advance their technology and expand their market reach.

Total raised
Undisclosed
across 2 rounds
Latest round
€16.2 million
Nov 12, 2026
Press coverage
2
outlets tracked

Is this your company?

Claim this profile to get matched with investors who fund DeepTech startups in Lithuania.

Claim this profile →

Funding history

  1. 2
    €16.2 millionNov 12, 2026
    Announcement ↗
  2. 1
    $18M Series ASeries ANov 12, 2026
    Announcement ↗

Biomatter in the news

Coverage of this company's funding, tracked by Datapile.

More DeepTech companies

Recently funded startups in the same category.

Related on Datapile